Copy

Sponsored by     

 

Daily Recap

After Ebola spills into Uganda, WHO decides against emergency declaration

By Helen Branswell

JOHN WESSELS/AFP/Getty Images

Though cases were detected in Uganda this week, they were spotted and isolated quickly and as yet, there is no evidence of transmission in a second country.

Read More

Amgen, Merck, and Eli Lilly sue over Trump administration policy to require drug prices in TV ads

By Lev Facher

Adobe

Amgen, Merck, Eli Lilly, and the Association of National Advertisers sued the Trump administration over a new policy to require drug prices in TV ads.

Read More

New evidence points to possible cause of puzzling paralysis in kids

By Maggie Fox

Cynthia S. Goldsmith, Yiting Zhang/CDC

The researchers hope their work will lead to a test for the condition, called acute flaccid myelitis, which has been diagnosed in more than 500 kids.

Read More

STAT Plus: Bluebird’s gene therapy for a rare blood disease will cost $1.8 million. Cue the pricing debate

By Adam Feuerstein

Ruby Wallau for STAT

Zynteglo, the one-and-done gene therapy for beta thalassemia newly approved in Europe, will carry a price tag of $1.8 million, Bluebird announced.

Read More

‘It felt like an ’80s criminal drama’: What happened when a biohacker met bureaucrats investigating him

By Rebecca Robbins and Adam Feuerstein and Damian Garde

Courtesy Josiah Zayner

Josiah Zayner explains what it's like to be investigated by California officials for his version of do-it-yourself science — and self-experimentation.

Read More

Friday, June 14, 2019

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2019, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us
5cP.gif?contact_status=<<Contact Status>>